Strategies to average down on MDGL - Entry Point & Safe Capital Growth Trade Ideas - Newser
7 hours ago • Google News
Madrigal Pharmaceuticals Inc (MDGL)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 9.47B
P/E Ratio
0.00
Revenue (TTM)
$ 515.55M
Volume
0
52W High
$ 437.06
52W Low
$ 200.63
Dividend Yield
0.00%
Beta
-1.03
Technicals
50-Day MA
326.1726
200-Day MA
318.5787
52 Week High
437.06
52 Week Low
200.63
About MDGL
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
Employees
528
Headquarters
West Conshohocken, PA
CEO
Mr. William J. Sibold
Latest News
Do You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)? - MSN
8 hours ago • Google News
Do You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)? - Yahoo Finance
3 days ago • Google News